Re-review completed for `doi__10.3390_md20030158`.

I repaired the worker-2/4/6 layers and closed `rwk-complete-test-0001` as `accepted_with_cautions`, not clean acceptance. Key outputs now show:

- `activity_records`: 54 source-located IC50 rows
- `database_record_audits`: 138, with `source_verified=118`, `source_conflict=20`
- `mechanism_claims`: 3 bounded anticancer mechanism claims
- `quality_feedback.issue_count`: 0
- `rework_targets`: []
- `unrecoverable_material_gaps`: []

Validation passed:

- [semantic gate](/root/work/抗菌肽/数据库/batch/4-team/reports/doi__10.3390_md20030158.semantic_gate.json): `issue_count=0`, `publication_grade_pass_count=1`
- [publication QA](/root/work/抗菌肽/数据库/batch/4-team/reports/doi__10.3390_md20030158.publication_quality.json): `publication_grade_pass=true`, `risk_counts={}`
- [complete report](/root/work/抗菌肽/数据库/batch/4-team/reports/doi__10.3390_md20030158.complete_message_test_report.json): `terminal_status=accepted_with_cautions_after_rework`, `open_rework_ticket_count=0`

Remaining cautions are preserved in the artifacts: one DBAASP Galaxamide target/value conflict and DRAMP unsupported antimicrobial/linear metadata conflicts. This directory is not a git repository, so verification was artifact/gate based.

